SAMANTHA AVENDANO: Open Payments
NPI 1609640648 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 92 payments from 10 companies in 2025. Trend: 2023 $160 · 2024 $2,355 · 2025 $2,414
Food & beverage: $2,314Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 25 | $741 |
| Janssen Biotech, Inc. | 14 | $358 |
| ABBVIE INC. | 16 | $298 |
| Novartis Pharmaceuticals Corporation | 11 | $248 |
| UCB, Inc. | 7 | $236 |
| Mallinckrodt Hospital Products Inc. | 7 | $205 |
| AstraZeneca Pharmaceuticals LP | 5 | $171 |
| Radius Health, Inc. | 3 | $83 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Genentech USA, Inc. | 1 | $22 |
Products named: TREMFYA, TAVNEOS, COSENTYX, Bimzelx, ACTHAR, RINVOQ, SAPHNELO, ENBREL.
Industry payments across TX — which companies pay providers there.
